Exact Sciences
EXAS
#1544
Rank
ยฃ8.73 B
Marketcap
ยฃ47.19
Share price
5.86%
Change (1 day)
-18.47%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Revenue for Exact Sciences (EXAS)

Revenue in 2024 (TTM): ยฃ2.09 Billion

According to Exact Sciences's latest financial reports the company's current revenue (TTM ) is ยฃ2.13 Billion. In 2023 the company made a revenue of ยฃ1.96 Billion an increase over the revenue in the year 2022 that were of ยฃ1.72 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Exact Sciences from 2001 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ2.09 B6.76%
2023 ยฃ1.96 B13.89%
2022 ยฃ1.72 B31.6%
2021 ยฃ1.30 B19.65%
2020 ยฃ1.09 B63.73%
2019 ยฃ0.66 B86.65%
2018 ยฃ0.35 B81.91%
2017 ยฃ0.19 B144.37%
2016 ยฃ80.53 M202.64%
2015 ยฃ26.61 M2204.37%
2014 ยฃ1.15 M-54.03%
2013 ยฃ2.51 M-2.01%
2012 ยฃ2.56 M-4.27%
2011 ยฃ2.67 M-22.63%
2010 ยฃ3.46 M17.74%
2009 ยฃ2.94 M
2007 ยฃ1.47 M-39.08%
2006 ยฃ2.42 M-1.6%
2005 ยฃ2.46 M-4.13%
2004 ยฃ2.57 M58.51%
2003 ยฃ1.62 M189.89%
2002 ยฃ0.55 M1494.45%
2001 ยฃ0.03 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ0.65 B-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.14 B-93.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.33 B-84.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ2.73 Million-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ42.51 B 1,887.39%๐Ÿ‡ซ๐Ÿ‡ท France